3 April 2023 in Anz Journal of Surgery
BackgroundSecondary aorto-enteric fistulae (SAEF) are a rare, complex and life-threatening complication following aortic repair. Traditional treatment strategy has been with open aortic repair (OAR), with emergence of endovascular repair (EVAR) as a potentially viable initial treatment option. Controversy exists over optimal immediate and long-term management. MethodsAn observational, retrospective, multi-institutional study of patients who had been treated for SAEF between 2003 and 2020 was performed using a standardized database. Baseline characteristics, presenting features, microbiological, operative and post-operative variables were recorded. The primary outcome was short and mid-term mortality. Descriptive statistics, Kaplan-Meier, Cox age-adjusted survival analysis and binomial regression analysis were performed. ResultsThere were 47 patients treated for SAEF identified, with a median (range) age at presentation of 74 (48-93) and 7 were females. Initially, there were 24 (51%) treated with OAR, 15 (32%) with EVAR and 8 (17%) non-operatively. The 30-day and 1-year mortality for all cases that underwent intervention was 21% and 46% respectively. Age-adjusted survival analysis revealed no statistically significant difference in mortality in the EVAR-first group compared to the OAR-first group, HR 0.99 (95% CI 0.94-1.03, P = 0.61). ConclusionIn this study there was no difference in all-cause survival in patients who had OAR or EVAR as first line treatment for SAEF. In the acute setting, alongside broad-spectrum antimicrobial therapy, EVAR can be considered as an initial treatment for patients with SAEF, as a primary treatment or a bridge to definitive OAR.
8 June 2022 in Anz Journal of Surgery
A(Australian And New Zealand Vascular Trial Network (Anzvtn)
Australian And New Zealand Vascular Trial Network (Anzvtn)
+44
Background Frailty predicts adverse perioperative outcomes and increased mortality in patients having vascular surgery. Frailty assessment is a potential tool to inform resource allocation, and shared decision-making about vascular surgery in the resource constrained COVID-19 pandemic environment. This cohort study describes the prevalence of frailty in patients having vascular surgery and the association between frailty, mortality and perioperative outcomes. Methods The COVID-19 Vascular Service in Australia (COVER-AU) prospective cohort study evaluates 30-day and six-month outcomes for consecutive patients having vascular surgery in 11 Australian vascular units, March-July 2020. The primary outcome was mortality, with secondary outcomes procedure-related outcomes and hospital utilization. Frailty was assessed using the nine-point visual Clinical Frailty Score, scores of 5 or more considered frail. Results Of the 917 patients enrolled, 203 were frail (22.1%). The 30 day and 6 month mortality was 2.0% (n = 20) and 5.9% (n = 35) respectively with no significant difference between frail and non-frail patients (OR 1.68, 95%CI 0.79-3.54). However, frail patients stayed longer in hospital, had more perioperative complications, and were more likely to be readmitted or have a reoperation when compared to non-frail patients. At 6 months, frail patients had twice the odds of major amputation compared to non-frail patients, after adjustment (OR 2.01; 95% CI 1.17-3.78), driven by a high rate of amputation during the period of reduced surgical activity. Conclusion Our findings highlight that older, frail patients, experience potentially preventable adverse outcomes and there is a need for targeted interventions to optimize care, especially in times of healthcare stress.
29 September 2023 in Anz Journal of Surgery
1 May 2014 in Journal of Trauma and Acute Care Surgery
22 November 2022 in Anz Journal of Surgery